Logo image of VTEX

VTEX -CLASS A (VTEX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:VTEX - KYG9470A1022 - Common Stock

3.37 USD
-0.23 (-6.39%)
Last: 1/15/2026, 8:24:40 PM
3.41 USD
+0.04 (+1.19%)
After Hours: 1/15/2026, 8:24:40 PM
Fundamental Rating

5

VTEX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 88 industry peers in the IT Services industry. While VTEX has a great health rating, its profitability is only average at the moment. VTEX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year VTEX was profitable.
  • In the past year VTEX had a positive cash flow from operations.
  • VTEX had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: VTEX reported negative operating cash flow in multiple years.
VTEX Yearly Net Income VS EBIT VS OCF VS FCFVTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • VTEX's Return On Assets of 4.65% is fine compared to the rest of the industry. VTEX outperforms 67.05% of its industry peers.
  • Looking at the Return On Equity, with a value of 6.81%, VTEX is in line with its industry, outperforming 59.09% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.15%, VTEX is in line with its industry, outperforming 55.68% of the companies in the same industry.
Industry RankSector Rank
ROA 4.65%
ROE 6.81%
ROIC 4.15%
ROA(3y)-5.13%
ROA(5y)-6.12%
ROE(3y)-6.69%
ROE(5y)-7.95%
ROIC(3y)N/A
ROIC(5y)N/A
VTEX Yearly ROA, ROE, ROICVTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • VTEX's Profit Margin of 7.03% is fine compared to the rest of the industry. VTEX outperforms 70.45% of its industry peers.
  • With a decent Operating Margin value of 5.99%, VTEX is doing good in the industry, outperforming 61.36% of the companies in the same industry.
  • VTEX has a better Gross Margin (76.21%) than 95.45% of its industry peers.
  • In the last couple of years the Gross Margin of VTEX has grown nicely.
Industry RankSector Rank
OM 5.99%
PM (TTM) 7.03%
GM 76.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.8%
GM growth 5Y1.94%
VTEX Yearly Profit, Operating, Gross MarginsVTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VTEX is destroying value.
  • The number of shares outstanding for VTEX has been increased compared to 1 year ago.
  • The number of shares outstanding for VTEX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, VTEX has an improved debt to assets ratio.
VTEX Yearly Shares OutstandingVTEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
VTEX Yearly Total Debt VS Total AssetsVTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • VTEX has an Altman-Z score of 4.22. This indicates that VTEX is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.22, VTEX is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • There is no outstanding debt for VTEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.22
ROIC/WACC0.47
WACC8.89%
VTEX Yearly LT Debt VS Equity VS FCFVTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • VTEX has a Current Ratio of 3.10. This indicates that VTEX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.10, VTEX is in the better half of the industry, outperforming 79.55% of the companies in the same industry.
  • VTEX has a Quick Ratio of 3.10. This indicates that VTEX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of VTEX (3.10) is better than 79.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 3.1
VTEX Yearly Current Assets VS Current LiabilitesVTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 91.30% over the past year.
  • The Revenue has been growing slightly by 3.62% in the past year.
  • VTEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.90% yearly.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)3.62%
Revenue growth 3Y21.69%
Revenue growth 5Y29.9%
Sales Q2Q%6.45%

3.2 Future

  • Based on estimates for the next years, VTEX will show a very strong growth in Earnings Per Share. The EPS will grow by 61.05% on average per year.
  • The Revenue is expected to grow by 9.10% on average over the next years. This is quite good.
EPS Next Y103.81%
EPS Next 2Y73.42%
EPS Next 3Y61.05%
EPS Next 5YN/A
Revenue Next Year5.08%
Revenue Next 2Y8.99%
Revenue Next 3Y10.96%
Revenue Next 5Y9.1%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VTEX Yearly Revenue VS EstimatesVTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
VTEX Yearly EPS VS EstimatesVTEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 37.44, the valuation of VTEX can be described as expensive.
  • VTEX's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of VTEX to the average of the S&P500 Index (27.54), we can say VTEX is valued slightly more expensively.
  • VTEX is valuated rather expensively with a Price/Forward Earnings ratio of 17.79.
  • 67.05% of the companies in the same industry are more expensive than VTEX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of VTEX to the average of the S&P500 Index (24.31), we can say VTEX is valued slightly cheaper.
Industry RankSector Rank
PE 37.44
Fwd PE 17.79
VTEX Price Earnings VS Forward Price EarningsVTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • VTEX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. VTEX is cheaper than 73.86% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, VTEX is valued a bit cheaper than the industry average as 68.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.83
EV/EBITDA 12.34
VTEX Per share dataVTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • VTEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as VTEX's earnings are expected to grow with 61.05% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y73.42%
EPS Next 3Y61.05%

0

5. Dividend

5.1 Amount

  • No dividends for VTEX!.
Industry RankSector Rank
Dividend Yield 0%

VTEX -CLASS A

NYSE:VTEX (1/15/2026, 8:24:40 PM)

After market: 3.41 +0.04 (+1.19%)

3.37

-0.23 (-6.39%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-06
Earnings (Next)02-23
Inst Owners37.5%
Inst Owner Change-0.02%
Ins Owners1.77%
Ins Owner ChangeN/A
Market Cap599.99M
Revenue(TTM)234.09M
Net Income(TTM)16.47M
Analysts82.5
Price Target7.36 (118.4%)
Short Float %5.22%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.1%
Min EPS beat(2)-37.25%
Max EPS beat(2)19.05%
EPS beat(4)2
Avg EPS beat(4)43.07%
Min EPS beat(4)-37.25%
Max EPS beat(4)198.04%
EPS beat(8)4
Avg EPS beat(8)46.17%
EPS beat(12)6
Avg EPS beat(12)33.68%
EPS beat(16)8
Avg EPS beat(16)25.22%
Revenue beat(2)0
Avg Revenue beat(2)-3.18%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)-1.94%
Revenue beat(4)1
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)0.43%
Revenue beat(8)2
Avg Revenue beat(8)-1.75%
Revenue beat(12)5
Avg Revenue beat(12)-1.11%
Revenue beat(16)8
Avg Revenue beat(16)-0.69%
PT rev (1m)-0.77%
PT rev (3m)-11.7%
EPS NQ rev (1m)-9.3%
EPS NQ rev (3m)-8.33%
EPS NY rev (1m)-0.98%
EPS NY rev (3m)11.96%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-2.32%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 37.44
Fwd PE 17.79
P/S 2.56
P/FCF 17.83
P/OCF 17.2
P/B 2.48
P/tB 2.91
EV/EBITDA 12.34
EPS(TTM)0.09
EY2.67%
EPS(NY)0.19
Fwd EY5.62%
FCF(TTM)0.19
FCFY5.61%
OCF(TTM)0.2
OCFY5.81%
SpS1.31
BVpS1.36
TBVpS1.16
PEG (NY)0.36
PEG (5Y)N/A
Graham Number1.66
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 6.81%
ROCE 5.26%
ROIC 4.15%
ROICexc 17.29%
ROICexgc 38.82%
OM 5.99%
PM (TTM) 7.03%
GM 76.21%
FCFM 14.37%
ROA(3y)-5.13%
ROA(5y)-6.12%
ROE(3y)-6.69%
ROE(5y)-7.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.8%
GM growth 5Y1.94%
F-Score8
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 35.82%
Cap/Sales 0.53%
Interest Coverage 250
Cash Conversion 199.92%
Profit Quality 204.32%
Current Ratio 3.1
Quick Ratio 3.1
Altman-Z 4.22
F-Score8
WACC8.89%
ROIC/WACC0.47
Cap/Depr(3y)21.4%
Cap/Depr(5y)35.19%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y103.81%
EPS Next 2Y73.42%
EPS Next 3Y61.05%
EPS Next 5YN/A
Revenue 1Y (TTM)3.62%
Revenue growth 3Y21.69%
Revenue growth 5Y29.9%
Sales Q2Q%6.45%
Revenue Next Year5.08%
Revenue Next 2Y8.99%
Revenue Next 3Y10.96%
Revenue Next 5Y9.1%
EBIT growth 1Y61.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.36%
EBIT Next 3Y56.17%
EBIT Next 5Y45.35%
FCF growth 1Y1166.77%
FCF growth 3YN/A
FCF growth 5Y153.63%
OCF growth 1Y1331.5%
OCF growth 3YN/A
OCF growth 5Y67.46%

VTEX -CLASS A / VTEX FAQ

Can you provide the ChartMill fundamental rating for VTEX -CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to VTEX.


What is the valuation status of VTEX -CLASS A (VTEX) stock?

ChartMill assigns a valuation rating of 5 / 10 to VTEX -CLASS A (VTEX). This can be considered as Fairly Valued.


Can you provide the profitability details for VTEX -CLASS A?

VTEX -CLASS A (VTEX) has a profitability rating of 4 / 10.


What are the PE and PB ratios of VTEX -CLASS A (VTEX) stock?

The Price/Earnings (PE) ratio for VTEX -CLASS A (VTEX) is 37.44 and the Price/Book (PB) ratio is 2.48.


What is the financial health of VTEX -CLASS A (VTEX) stock?

The financial health rating of VTEX -CLASS A (VTEX) is 8 / 10.